Literature DB >> 23108408

miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.

N Kliese1, P Gobrecht, D Pachow, N Andrae, A Wilisch-Neumann, E Kirches, M Riek-Burchardt, F Angenstein, G Reifenberger, M J Riemenschneider, E Meese, D Panayotova-Dimitrova, D H Gutmann, C Mawrin.   

Abstract

Meningiomas are frequent, mostly benign intracranial or spinal tumors. A small subset of meningiomas is characterized by histological features of atypia or anaplasia that are associated with more aggressive biological behavior resulting in increased morbidity and mortality. Infiltration into the adjacent brain tissue is a major factor linked to higher recurrence rates. The molecular mechanisms of progression, including brain invasion are still poorly understood. We have studied the role of micro-RNA 145 (miR-145) in meningiomas and detected significantly reduced miR-145 expression in atypical and anaplastic tumors as compared with benign meningiomas. Overexpression of miR-145 in IOMM-Lee meningioma cells resulted in reduced proliferation, increased sensitivity to apoptosis, reduced anchorage-independent growth and reduction of orthotopic tumor growth in nude mice as compared with control cells. Moreover, meningioma cells with high miR-145 levels had impaired migratory and invasive potential in vitro and in vivo. PCR-array studies of miR145-overexpressing cells suggested that collagen type V alpha (COL5A1) expression is downregulated by miR-145 overexpression. Accordingly, COL5A1 expression was significantly upregulated in atypical and anaplastic meningiomas. Collectively, our data indicate an important anti-migratory and anti-proliferative function of miR-145 in meningiomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108408     DOI: 10.1038/onc.2012.468

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

Authors:  Ebru Esin Yoruker; Fatma Aydoğan; Uğur Gezer; Pinar Saip; Nejat Dalay
Journal:  Mol Clin Oncol       Date:  2015-05-13

2.  Perturbation of epigenetic processes by doxorubicin in the mouse testis.

Authors:  Oluwajoba O Akinjo; Timothy W Gant; Emma L Marczylo
Journal:  Toxicol Res (Camb)       Date:  2016-06-01       Impact factor: 3.524

3.  Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.

Authors:  Nicole Ludwig; Yoo-Jin Kim; Sabine C Mueller; Christina Backes; Tamara V Werner; Valentina Galata; Elke Sartorius; Rainer M Bohle; Andreas Keller; Eckart Meese
Journal:  Neuro Oncol       Date:  2015-02-13       Impact factor: 12.300

4.  ARID1A and TERT promoter mutations in dedifferentiated meningioma.

Authors:  Malak S Abedalthagafi; Wenya Linda Bi; Parker H Merrill; William J Gibson; Matthew F Rose; Ziming Du; Joshua M Francis; Rose Du; Ian F Dunn; Azra H Ligon; Rameen Beroukhim; Sandro Santagata
Journal:  Cancer Genet       Date:  2015-03-18

Review 5.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

6.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

7.  Re-evaluation of cytostatic therapies for meningiomas in vitro.

Authors:  Annette Wilisch-Neumann; Doreen Pachow; Maren Wallesch; Astrid Petermann; Frank D Böhmer; Elmar Kirches; Christian Mawrin
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

8.  Expression of c-MET in Invasive Meningioma.

Authors:  Sumi Yun; Jae Moon Koh; Kyu Sang Lee; An Na Seo; Kyung Han Nam; Gheeyoung Choe
Journal:  J Pathol Transl Med       Date:  2015-01-15

Review 9.  Epigenetics of Meningiomas.

Authors:  Balázs Murnyák; László Bognár; Álmos Klekner; Tibor Hortobágyi
Journal:  Biomed Res Int       Date:  2015-05-25       Impact factor: 3.411

Review 10.  MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).

Authors:  Xiang-Ming Ding
Journal:  Chin J Cancer       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.